Physics

Shingles Vaccine Tied to Reduced Dementia Risk
— Recombinant Shingles Vaccine Linked to 164 Days Free from Dementia Diagnosis Key Points Those who received the recombinant shingles vaccine (Shingrix) saw a 17% longer duration without a dementia diagnosis compared to patients who got the live vaccine version. This extension translates to 164 more days on average without receiving a dementia diagnosis. The findings add to the growing understanding of a potential link between shingles vaccination and the prevention of dementia. A recent
Shingles Vaccine Tied to Reduced Dementia Risk
3294 likes 118 162 views
Jon Stewart Urges VA to Assist Veterans Affected by Post-9/11 Uranium Exposure
— Numerous veterans report severe health issues, many tied to radiation exposure Renowned comedian and activist Jon Stewart is urging the Biden administration to address an oversight in the expansive PACT Act, a veterans assistance bill, which neglected to cover American soldiers who were among the first responders post-9/11, and later fell ill after being stationed at a base heavily contaminated with radiation. In the months following the September 11 attacks, U.S. special operations forces
Jon Stewart Urges VA to Assist Veterans Affected by Post-9/11 Uranium Exposure
3379 likes 120 186 views
Oregon State researchers record two shark species in Puget Sound for the first time
CORVALLIS, Oregon – In a groundbreaking discovery, researchers from Oregon State University have confirmed the presence of two distinct shark species in Puget Sound for the first time, with one being critically endangered. The documented species—broadnose sevengill shark and the endangered soupfin shark—have been found in this vital section of the Salish Sea, a body of water recognized for its economic, cultural, and ecological significance, according to biologists from OSU’s Big Fish Lab. The
Oregon State researchers record two shark species in Puget Sound for the first time
3469 likes 120 154 views
Advancing solar potential: a breakthrough in perovskite solar cell innovation
Perovskite solar cells (PSCs) have received considerable acclaim for their outstanding photovoltaic capabilities and cost-effectiveness. One of the major challenges, however, lies in the steep costs associated with charge transport materials. Traditional materials such as 2,2',7,7'-Tetrakis[N,N-di(4-methoxyphenyl)amino]-9,9'-spirobifluorene (Spiro-OMeTAD) are expensive and difficult to manufacture. As a result, there is an urgent need to identify inexpensive yet efficient
Advancing solar potential: a breakthrough in perovskite solar cell innovation
3408 likes 119 509 views
Nasal Sprays for Treating Respiratory Infections; Paxlovid's Role in COVID Prevention
— Also on TTHealthWatch: Pediatric Diabetes Post-COVID TTHealthWatch is a weekly podcast from Texas Tech, hosted by Elizabeth Tracey, the director of electronic media at Johns Hopkins, and Dr. Rick Lange, president of Texas Tech University Health Sciences Center, El Paso. Each week, they delve into the most significant medical news. This episode's discussions include topics such as the efficacy of nasal sprays for respiratory infections, the preventive use of Paxlovid, endometriosis and
3344 likes 119 849 views
Insufficient Institutional Backing is a Leading Cause of Doctor Reluctance in Addressing Addiction
— Lack of Institutional Support and Knowledge rank as Key Factors A recent systematic review of 283 studies has determined that a lack of institutional backing remains the top reason clinicians hesitate to intervene in addiction cases, as highlighted by the findings. In their analysis, Wilson Compton, MD, MPE, deputy director of the National Institute on Drug Abuse (NIDA), and his colleagues reported in JAMA Network Open that 81.2% of the reviewed articles cited the institutional environment as
Insufficient Institutional Backing is a Leading Cause of Doctor Reluctance in Addressing Addiction
3498 likes 121 039 views
Hormone Therapy May Lower Dementia Risk in Certain Older Breast Cancer Patients
— Age-Related Outcomes A retrospective analysis involving Medicare patients suggested that hormone therapy in older women with breast cancer was linked to a lower risk of developing dementia. The study showed that breast cancer patients who underwent hormone-modulating therapy had a 7% reduced likelihood of dementia over an average follow-up of 12 years compared with those who didn’t receive the therapy (HR 0.93, 95% CI 0.88-0.98, P=0.005), according to research led by Chao Cai, PhD, from the
Hormone Therapy May Lower Dementia Risk in Certain Older Breast Cancer Patients
3585 likes 123 354 views